Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.

被引：22
|
作者：
Gomez-Roca, Carlos Alberto
Cassier, Philippe Alexandre
Italiano, Antoine
Cannarile, Michael
Ries, Carola
Brillouet, Anne
Mueller, Claudia
Jegg, Anna-Maria
Meneses-Lorente, Georgina
Baehner, Monika
Abiraj, Keelara
Loirat, Delphine
Toulmonde, Maud
D'Angelo, Sandra P.
Weber, Kristy
Campone, Mario
Ruettinger, Dominik
Blay, Jean-Yves
Delord, Jean-Pierre
Le Tourneau, Christophe
机构：
[1] Inst Claudius Regaud, Dept Med, Toulouse, France
[2] Ctr Leon Berard, Dept Med, F-69373 Lyon, France
[3] CLCC Inst Bergonie, Bordeaux, France
[4] Roche Pharma Res & Early Dev Oncol, Penzberg, Germany
[5] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Penzberg, Penzberg, Germany
[6] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland
[7] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Welwyn, Welwyn Garden City, England
[8] Inst Curie, Dept Med Oncol, Paris, France
[9] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
[12] Canc Inst West ICO, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3005
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I and pharmacokinetic study of PEG-camptothecin in patients with advanced solid tumors.
    Hao, D
    Tolcher, AW
    Rizzo, JD
    Ochoa, L
    McCreery, H
    Schwartz, GH
    Patnaik, A
    Denis, LJ
    Hammond, LA
    Hidalgo, M
    Kwiatek, J
    McGuire, J
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4513S - 4513S
  • [42] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Vaena, Daniel A.
    Sullivan, Ryan J.
    Luke, Jason J.
    ElNaggar, Adam
    Hunter, John
    Adewoye, Adeboye H.
    Olweny, Judy
    Patnaik, Amita
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [45] A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors.
    Calvert, PM
    Highley, MS
    Hughes, AN
    Plummer, ER
    Azzabi, AST
    Verrill, MW
    Camboni, MG
    Verdi, E
    Bernareggi, A
    Zucchetti, M
    Robinson, AM
    Carmichael, J
    Calvert, AH
    CLINICAL CANCER RESEARCH, 1999, 5 : 3796S - 3796S
  • [46] A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors.
    Schmid, P
    Kiewe, P
    Kuehnhardt, D
    Korfel, A
    Lindemann, S
    Giurescu, M
    Reif, S
    Thiel, E
    Possinger, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 147S - 147S
  • [47] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [48] Safety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study
    Ho, Ching-Liang
    Chao, Tsu-Yi
    Chang, Chia-Lun
    Lin, Hsuan-Yu
    BIODRUGS, 2024, 38 (02) : 287 - 299
  • [49] Safety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study
    Ching-Liang Ho
    Tsu-Yi Chao
    Chia-Lun Chang
    Hsuan-Yu Lin
    BioDrugs, 2024, 38 : 287 - 299
  • [50] Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors.
    Collins, Julie Marie
    Heery, Christopher Ryan
    Donahue, Renee Nicole
    Palena, Claudia
    Madan, Ravi Amrit
    Strauss, Julius
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345